Cargando…

Native T1 lowering in iron overload and Anderson Fabry disease; a novel and early marker of disease

Detalles Bibliográficos
Autores principales:	Sado, Daniel, White, Steven K, Piechnik, Stefan K, Banypersad, Sanjay M, Treibel, Thomas A, Fontana, Marianna, Captur, Gaby, Maestrini, Viviana, Lachmann, Robin, Hughes, Derralyn, Murphy, Elaine, Porter, John, Mehta, Atul, Elliott, Perry, Moon, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559660/ http://dx.doi.org/10.1186/1532-429X-15-S1-O71

Ejemplares similares

Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance
por: Pica, Silvia, et al.
Publicado: (2014)

The distribution of hypertrophy in anderson fabry disease
por: Sado, Daniel M, et al.
Publicado: (2011)

AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology
por: Fontana , Marianna, et al.
Publicado: (2014)

Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
por: Fontana, Marianna, et al.
Publicado: (2014)

Clinical prodromes of neurodegeneration in Anderson-Fabry disease
por: Löhle, Matthias, et al.
Publicado: (2015)

Biomarkers in Anderson–Fabry Disease
por: Simonetta, Irene, et al.
Publicado: (2020)

Cardiac amyloid burden assessment by T1 mapping predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study
por: Banypersad, Sanjay M, et al.
Publicado: (2014)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Anderson-Fabry disease in heart failure
por: Akhtar, M. M., et al.
Publicado: (2018)

Myocardial iron quantification using T2* and native T1mapping - a 250 patient study
por: Abdel-Gadir, Amna, et al.
Publicado: (2015)

Variable myocardial interstitial expansion by T1 mapping within LGE area in infarction and hypertrophic cardiomyopathy
por: Maestrini, Viviana, et al.
Publicado: (2013)

Time of Anderson-Fabry Disease Detection and Cardiovascular Presentation
por: Selthofer-Relatic, K.
Publicado: (2018)

T1 mapping and survival in systemic light-chain amyloidosis
por: Banypersad, Sanjay M., et al.
Publicado: (2015)

Pathologic substrate of gastropathy in Anderson-Fabry disease
por: Di Toro, Alessandro, et al.
Publicado: (2020)

Reduced native right ventricular T(1 )in Anderson-Fabry disease as compared to patients with pulmonary hypertension
por: Pagano, Joseph J, et al.
Publicado: (2014)

Agalsidase alfa (Replagal(™)) in the treatment of Anderson-Fabry disease
por: Pastores, Gregory M
Publicado: (2007)

Interstitial expansion in health and disease - an equilibrium contrast CMR study
por: Sado, Daniel, et al.
Publicado: (2012)

Single breath-hold Vd(m) calculation as good as multi breath-hold technique in Equilibrium Contrast CMR
por: Sado, Daniel, et al.
Publicado: (2012)

Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR
por: Fontana, Marianna, et al.
Publicado: (2012)

Interstitial expansion in pressure overload left ventricular hypertrophy
por: Treibel, Thomas A, et al.
Publicado: (2013)

Myocardial native T1 and extracellular volume with healthy ageing and gender
por: Rosmini, Stefania, et al.
Publicado: (2018)

Reduced Right Ventricular Native Myocardial T(1) in Anderson-Fabry Disease: Comparison to Pulmonary Hypertension and Healthy Controls
por: Pagano, Joseph J., et al.
Publicado: (2016)

Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: a systematic review and meta-analysis
por: Ponsiglione, Andrea, et al.
Publicado: (2022)

CMR demonstration of multiple morphological phenotypes in Anderson-Fabry disease
por: Deva, Djeven P, et al.
Publicado: (2015)

Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review
por: Caputo, Fabio, et al.
Publicado: (2021)

Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future
por: Esposito, Roberta, et al.
Publicado: (2021)

Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies
por: Stamerra, Cosimo A., et al.
Publicado: (2021)

Advanced CMR Techniques in Anderson-Fabry Disease: State of the Art
por: Ponsiglione, Andrea, et al.
Publicado: (2023)

Diffuse interstitial fibrosis in well-controlled hypertension
por: Treibel, Thomas A, et al.
Publicado: (2013)

Anderson–Fabry Disease: A New Piece of the Lysosomal Puzzle in Parkinson Disease?
por: Zedde, Marialuisa, et al.
Publicado: (2022)

Angiokeratoma Corporis Diffusum: An Uncommon Case with Suspected Anderson Fabry Disease
por: Vadher, Priyanka, et al.
Publicado: (2020)

Anderson-fabry disease: role of traditional and new cardiac MRI techniques
por: Caredda, Gloria, et al.
Publicado: (2021)

T1 mapping for myocardial extracellular volume measurement by cardiovascular magnetic resonance: bolus only vs primed infusion technique
por: White, Steven K, et al.
Publicado: (2013)

Role of cardiac imaging in Anderson-Fabry cardiomyopathy
por: Serra, Walter, et al.
Publicado: (2019)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
por: Karamitsos, Theodoros, et al.
Publicado: (2012)

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
por: Duro, Giovanni, et al.
Publicado: (2018)

Anderson-Fabry’s Disease: A Rare but Treatable Case of Fever of Unknown Origin
por: Graziani, Francesca, et al.
Publicado: (2017)

Clinical Diversity in Patients with Anderson-fabry Disease with the R301Q Mutation
por: Yamamoto, Saori, et al.
Publicado: (2018)

Biomarkers and Imaging Findings of Anderson–Fabry Disease—What We Know Now
por: Beirão, Idalina, et al.
Publicado: (2017)

Prognostic significance of right ventricular hypertrophy and systolic function in Anderson–Fabry disease
por: Graziani, Francesca, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6cj6qkbeacdtmdq8a8tur7k6pt